Veea and Totalplay Advance Commercial Plans for Secure, AI-Powered Business Services in Mexico 
Building An AM Quality Data Backbone That Makes AI Credible 
Visionstate Announces $750,000 financing to Support International Expansion and Strategic Growth 
Local AI Registry Launches First Public Registry of AI Business Recommendations 
Agereh Technologies to Attend 2026 ACI-NA Annual Conference & Exhibition in Philadelphia Iterum Therapeutics plc Announces $35.0 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market under Nasdaq Rules
DUBLIN, Ireland and CHICAGO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct Offering
LAKE FOREST, Ill., Feb. 10, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
ObsEva Provides Business Outlook for 2021
GENEVA, Switzerland and BOSTON, MA (February 10, 2021) – ObsEva SA (NASDAQ: OBSV; SIX:…
Basilea reports positive topline results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene fusion-positive patients with bile duct cancer (iCCA)
Clinical proof of concept achieved for derazantinib monotherapy in FGFR2 gene fusion-positive iCCA 20.4% objective…
Autolus Announces Pricing of Public Offering
LONDON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical…
Vallon Pharmaceuticals Announces Pricing of Initial Public Offering
PHILADELPHIA, PA, Feb. 09, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (the “Company”), a clinical-stage…
Enlivex Increases Previously Announced Bought Deal Offering to Approximately $46.0 Million of Ordinary Shares
Nes Ziona, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…
Oncorus Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Oncorus, Inc. (Nasdaq: ONCR), a clinical stage…
Andy Hurley Named Agenus Chief Commercial Officer
LEXINGTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma
FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma…
Enlivex Announces $10 Million Bought Deal Offering of Ordinary Shares
Nes Ziona, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (NASDAQ: ENLV), a…
GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology
Lille, France; Cambridge, MA; February 09, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Codiak Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a…
Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb….
Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference
Press Release – No. 7 / 2021 Copenhagen, DK and Boston, MA, February 9, 2021 – Zealand…
Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent Private Placement
PRESS RELEASE Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial…
Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
UNIONDALE, N.Y., Feb. 09, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage…
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
CHATHAM, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) — TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or…
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update
U.S. FDA reviewing premarket approval (PMA) submission for LungFitTM PH to treat persistent pulmonary hypertension…
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March
CANTON, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…